Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Thiotepa × Clear all

NCT01057069 2022-10-12

neo-TN

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT00448266 2021-01-22

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Phase 2/3 Terminated

Breast Neoplasms